Zylox-Tonbridge Medical Technology Co., Ltd.
Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices China and internationally. It primarily offers ThromBite Clot Retriever Device, which is intended to restore bl…
Medical - Devices
CN, Hangzhou [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | 0.00 | 5.40 | 5.40 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | -0.39 | 42.17 | 42.33 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Book Value | 0.00 | 9.30 | 9.30 | |
| Cash | 4.77 | 4.61 | 4.40 | |
| Capex | 0.00 | -0.12 | -0.12 | |
| Free Cash Flow | 0.00 | 0.06 | 0.06 | |
| Revenue | 0.00 | 0.45 | 0.45 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | 0.00 | 0.72 | 0.72 | |
| Operating Margin | 0.00 | -0.22 | -0.22 | |
| ROA | 0.00 | < 0.005 | < 0.005 | |
| ROE | 0.00 | < 0.005 | < 0.005 | |
| ROIC | 0.13 | -0.01 | -0.01 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of 2190.HK is permitted for members.
5
Growth
The "Growth Entry" for the Focus of 2190.HK is permitted for members.
6
Leverage & Liquidity